EE200100677A - Morfiini sisaldav farmatseutiline preparaat ninasiseseks manustamiseks ning meetod valuvaigistava või tuimastava reaktsiooni esilekutsumiseks imetajal - Google Patents

Morfiini sisaldav farmatseutiline preparaat ninasiseseks manustamiseks ning meetod valuvaigistava või tuimastava reaktsiooni esilekutsumiseks imetajal

Info

Publication number
EE200100677A
EE200100677A EEP200100677A EEP200100677A EE200100677A EE 200100677 A EE200100677 A EE 200100677A EE P200100677 A EEP200100677 A EE P200100677A EE P200100677 A EEP200100677 A EE P200100677A EE 200100677 A EE200100677 A EE 200100677A
Authority
EE
Estonia
Prior art keywords
morphine
analgesic
mammal
inducing
pharmaceutical preparation
Prior art date
Application number
EEP200100677A
Other languages
English (en)
Estonian (et)
Inventor
G. Achari Raja
R. Behl Charanjit
C. Demeireles Jorge
Dua Ramneik
D. Romeo Vincent (Surnud)
P. Sileno Anthony
Original Assignee
Nastech Pharmaceutical Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nastech Pharmaceutical Co., Inc. filed Critical Nastech Pharmaceutical Co., Inc.
Priority to EEP200300555A priority Critical patent/EE200300555A/xx
Publication of EE200100677A publication Critical patent/EE200100677A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EEP200100677A 1999-06-16 2000-05-23 Morfiini sisaldav farmatseutiline preparaat ninasiseseks manustamiseks ning meetod valuvaigistava või tuimastava reaktsiooni esilekutsumiseks imetajal EE200100677A (et)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EEP200300555A EE200300555A (et) 1999-06-16 2000-05-23 Morfiini sisaldav farmatseutiline preparaat ninasiseseks manustamiseks ning meetod valuvaigistava või tuimastava reaktsiooni esilekutsumiseks imetajal

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33453799A 1999-06-16 1999-06-16
PCT/US2000/014157 WO2000076506A1 (fr) 1999-06-16 2000-05-23 Formulations pharmaceutiques et procedes comprenant de la morphine s'administrant par voie intra-nasale

Publications (1)

Publication Number Publication Date
EE200100677A true EE200100677A (et) 2003-02-17

Family

ID=23307687

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100677A EE200100677A (et) 1999-06-16 2000-05-23 Morfiini sisaldav farmatseutiline preparaat ninasiseseks manustamiseks ning meetod valuvaigistava või tuimastava reaktsiooni esilekutsumiseks imetajal

Country Status (30)

Country Link
US (1) US6677346B1 (fr)
EP (2) EP1183027A4 (fr)
JP (1) JP2003501467A (fr)
KR (1) KR20020016831A (fr)
AU (1) AU774175B2 (fr)
BG (1) BG106221A (fr)
BR (1) BR0012082A (fr)
CA (1) CA2374877C (fr)
CZ (1) CZ20014399A3 (fr)
DE (1) DE10084709T1 (fr)
DK (1) DK200101859A (fr)
EE (1) EE200100677A (fr)
ES (1) ES2197792B1 (fr)
FI (1) FI20012462L (fr)
GB (1) GB2367005A (fr)
HR (1) HRP20010926A2 (fr)
HU (1) HUP0201856A3 (fr)
IS (1) IS6202A (fr)
LT (1) LT4976B (fr)
LU (1) LU90859B1 (fr)
LV (1) LV12859B (fr)
MX (1) MXPA01012879A (fr)
NO (1) NO20015931L (fr)
NZ (1) NZ515783A (fr)
PL (1) PL352556A1 (fr)
SE (1) SE0104203D0 (fr)
SI (1) SI20850A (fr)
SK (1) SK18172001A3 (fr)
TR (1) TR200103613T2 (fr)
WO (1) WO2000076506A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9924797D0 (en) 1999-10-20 1999-12-22 West Pharm Serv Drug Res Ltd Compound
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
CA2423354C (fr) * 2000-09-20 2009-12-15 Lee Shahinian Jr. Preparations et medications nasales, inhalables et ophtalmiques locales a conservation spontanee
EP1418862A4 (fr) * 2001-06-29 2010-06-09 Leon J Lewandowski Therapie de sevrage individualisee en cas de dependance
GB0210264D0 (en) * 2002-05-03 2002-06-12 Arakis Ltd The treatment of pain and migraine headache
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
US20050175679A1 (en) * 2004-02-10 2005-08-11 Michael Moshman Controlled release formulations
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
DK2486942T3 (en) 2004-11-24 2019-01-28 Meda Pharmaceuticals Inc COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
US9415034B2 (en) * 2005-01-05 2016-08-16 National Defense Medical Center Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
ES2277743B2 (es) * 2005-06-02 2008-12-16 Universidade De Santiago De Compostela Nanoparticulas que comprenden quitosano y ciclodextrina.
WO2007025286A2 (fr) * 2005-08-26 2007-03-01 The Board Of Trustees Of The Leland Stanford Junior University Methode d'administration de medicaments pour traitement de la douleur trigeminale
US20070212307A1 (en) * 2006-02-10 2007-09-13 Daniel Wermeling Pharmaceutical Compositions Comprising an Opioid Receptor Antagonist and Methods of Using Same
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
WO2008077712A1 (fr) * 2006-12-22 2008-07-03 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Gel utile pour l'administration de médicaments ophtalmiques
GB2477545B (en) * 2010-02-05 2011-12-21 Special Products Ltd A liquid morphine composition for buccal administration
DK2706982T4 (da) 2011-05-13 2021-05-10 Euro Celtique Sa Intranasale farmaceutiske dosisformer omfattende naloxon
AU2012386221A1 (en) 2012-07-26 2015-02-26 Wockhardt Limited Pharmaceutical composition comprising diamorphine for intranasal administration
EP3082817A4 (fr) * 2013-12-18 2017-06-21 Aegis Therapeutics, LLC Compositions pour administration de médicaments
US11135155B2 (en) 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US11389473B2 (en) 2015-01-07 2022-07-19 Tonix Pharmaceuticals Holding Corp. Magnesium-containing oxytocin formulations and methods of use
MX2018012351A (es) 2016-04-12 2019-02-07 Trigemina Inc Formulaciones de oxitocina que contienen magnesio y metodos de uso.
AU2017345767A1 (en) * 2016-10-21 2019-05-16 Somniferum Labs LLC Apparatus for controlled delivery of opioid and other medications
MA50394A (fr) * 2017-10-20 2021-04-28 Chiesi Farm Spa Formulations pharmaceutiques comprenant un agoniste de récepteur d'opioïde en tant que substances actives, leurs procédés de fabrication et leurs utilisations thérapeutiques
EA202091615A1 (ru) 2018-12-21 2021-03-05 Аегис Терапьютикс, Ллс Интраназальные составы на основе эпинефрина и способы лечения заболевания
CN115804754A (zh) * 2022-12-16 2023-03-17 广州新济药业科技有限公司 吗啡鼻喷剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464378A (en) 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
US4464376A (en) 1982-07-22 1984-08-07 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
US5202128A (en) 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
DE69434304T2 (de) * 1993-03-26 2005-12-29 Merkus, Franciscus Wilhelmus H.M. Pharmazeutische Zusammensetzungen zur intranasalen Verabreichung von Dihydroergotamin
GB9426102D0 (en) 1994-12-23 1995-02-22 Merck Sharp & Dohme Pharmacuetical compositions
US5874450A (en) * 1996-09-27 1999-02-23 Nastech Pharmaceutical Company, Inc. Intranasal formulations for promoting sleep and method of using the same

Also Published As

Publication number Publication date
EP1419774A1 (fr) 2004-05-19
LT2001119A (en) 2002-07-25
SE0104203L (sv) 2001-12-14
FI20012462A7 (fi) 2002-01-16
BG106221A (bg) 2002-08-30
HUP0201856A3 (en) 2004-12-28
GB2367005A (en) 2002-03-27
TR200103613T2 (tr) 2004-08-23
CA2374877C (fr) 2004-04-13
HUP0201856A1 (en) 2002-09-28
PL352556A1 (en) 2003-08-25
SE0104203D0 (sv) 2001-12-14
NO20015931L (no) 2002-02-08
DE10084709T1 (de) 2002-09-26
KR20020016831A (ko) 2002-03-06
EP1183027A1 (fr) 2002-03-06
SI20850A (sl) 2002-10-31
LU90859B1 (en) 2002-01-24
CZ20014399A3 (cs) 2002-06-12
DK200101859A (da) 2001-12-12
NZ515783A (en) 2004-05-28
BR0012082A (pt) 2002-05-07
JP2003501467A (ja) 2003-01-14
CA2374877A1 (fr) 2000-12-21
ES2197792A1 (es) 2004-01-01
ES2197792B1 (es) 2005-05-01
WO2000076506A1 (fr) 2000-12-21
AU774175B2 (en) 2004-06-17
IS6202A (is) 2001-12-14
AU5156100A (en) 2001-01-02
NO20015931D0 (no) 2001-12-04
FI20012462L (fi) 2002-01-16
SK18172001A3 (sk) 2002-07-02
LT4976B (lt) 2002-12-30
EP1183027A4 (fr) 2003-02-05
HRP20010926A2 (en) 2003-04-30
US6677346B1 (en) 2004-01-13
LV12859B (en) 2002-12-20
GB0128383D0 (en) 2002-01-16
MXPA01012879A (es) 2003-06-24

Similar Documents

Publication Publication Date Title
NO2010006I1 (no) Saksagliptin og farmasytisk akseptable salter derav inklusive saksagliptin hydroklorid
NO20040968L (no) Opioidagonistpreparater med frigjorbar og sekvestrert antagonist
AU2002236647A1 (en) Method and device for administering medication and/or placebo
DE69816325D1 (de) Gepufferte arzneistoffformulierungen zur transdermalen verabreichung durch elektrotransport
NO2011021I1 (no) Apixaban og farmasøytiske akseptable salter derav
EE05157B1 (et) N-[(asendatud bensüül)-4-piperidinüüli v?i pürrolidinüül]aminohüdroksüalkoksüfenüülide derivaadid, meetod nende valmistamiseks ning nende kasutamine meditsiinis
FI20012462A7 (fi) Farmaseuttisia formulaatioita ja menetelmiä käsittäen intranasaalista morfiinia
AU6271401A (en) Drug administering system and administering method
DK1158970T3 (da) Kombinationer af formoterol og et tiotropiumsalt
NO2008001I1 (no) Vildagliptin og farmasoytisk akseptable salter derav
NO975831D0 (no) Nytt farmasöytisk preparat med anestetisk virkning
FR14C0080I2 (fr) Methode d'administration d'un anticorps
CY2013011I1 (el) Μεθοδος χορηγησης διφωσφονικων
EE05067B1 (et) Aminoproplfosfiinhapped ning nende kasutamine meditsiinis
EE200300371A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kopmositsioonid
NO2005007I2 (no) Pemetrexed og farmasoytisk akseptable salter derav
EP1299337A4 (fr) Hydroxyphenstatine et promedicaments associes
NO20026212L (no) Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
BR0015939B1 (pt) Sistema terapêutico transdérmico com estabilidade aperfeiçoada e processo para a sua preparação
IS6723A (is) 10-arýl-11H-bensó[b]flúorenafleiður og hliðstæðurtil lyfjanotkunar
NO20034413D0 (no) Beta-karbolinderivater og deres farmasöytiske anvendelse mot depresjon og angst
NO20023448D0 (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
EE200300555A (et) Morfiini sisaldav farmatseutiline preparaat ninasiseseks manustamiseks ning meetod valuvaigistava või tuimastava reaktsiooni esilekutsumiseks imetajal
DE60122134D1 (de) Arzneimittelansprechmessverfahren und einrichtung dafür
GB0007788D0 (en) Method to evaluate the therapeutic and toxic effects related to drug administration